3//SEC Filing
Alset International Ltd 3
Accession 0001493152-22-019351
CIK 0000771999other
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 8:39 PM ET
Size
5.9 KB
Accession
0001493152-22-019351
Insider Transaction Report
Form 3
DSS, INC.DSS
Alset International Ltd
10% Owner
Holdings
- 6,232,671(indirect: See Footnote)
Common Stock
- 21,366,177
Common Stock
Footnotes (2)
- [F1]21,366,177 shares of the common stock of DSS, Inc. (the "Issuer") are held directly by Alset International Limited ("AIL"). These shares were acquired on July 12, 2022 pursuant to an assignment and assumption agreement (the "Agreement") between the Issuer and AIL dated February 28, 2022, as amended on July 12, 2022. Pursuant to the Agreement, as amended, the Issuer agreed to purchase a convertible promissory note from AIL (the "Note"). The Note has a principal amount of $8,350,000 and accrued but unpaid interest of $367,400. The Note was issued by American Medical REIT, Inc., a Maryland corporation. The consideration paid for the Note was 21,366,177 shares of the Issuer's common stock. The consideration was calculated by dividing $8,717,400, the aggregate of the principal amount and the accrued but unpaid interest under the Note, by $0.408 per share.
- [F2]6,232,671 shares of the common stock of the Issuer are held by Global Biomedical Pte. Ltd., a subsidiary of AIL.
Documents
Issuer
DSS, INC.
CIK 0000771999
Entity typeother
IncorporatedSingapore
Related Parties
1- filerCIK 0001660984
Filing Metadata
- Form type
- 3
- Filed
- Jul 13, 8:00 PM ET
- Accepted
- Jul 14, 8:39 PM ET
- Size
- 5.9 KB